Management of cardiogenic shock.

Journal Article (Journal Article;Review)

Cardiogenic shock (CS) remains the most common cause of death in patients with acute myocardial infarction although mortality could be reduced from formerly ∼80% to 40-50%. In addition to percutaneous coronary intervention or coronary artery bypass grafting, catecholamines, fluids, intraaortic balloon pumping (IABP), and also active assist devices are widely used for CS management. However, there is only limited evidence for any of the above treatments except for early revascularization and the relative ineffectiveness of IABP. This updated review will therefore outline the management of CS complicating acute myocardial infarction with major focus on evidence-based revascularization techniques, intensive care unit treatment including ventilation, transfusion regimens, adjunctive medication, and mechanical support devices.

Full Text

Duke Authors

Cited Authors

  • Thiele, H; Ohman, EM; Desch, S; Eitel, I; de Waha, S

Published Date

  • May 21, 2015

Published In

Volume / Issue

  • 36 / 20

Start / End Page

  • 1223 - 1230

PubMed ID

  • 25732762

Electronic International Standard Serial Number (EISSN)

  • 1522-9645

Digital Object Identifier (DOI)

  • 10.1093/eurheartj/ehv051


  • eng

Conference Location

  • England